Should We Build a Better Human?

Juan Enriquez & Eric Schadt, moderated by David Ewing Duncan

Arc Fusion Dinner | San Francisco | May 1, 2014

Should we take advantage of currently emerging technologies to make healthy people even healthier? Should we engineer ourselves by using bionic technology, stem cells and super pills to create a better society, and will this optimization ultimately create a new species?


Juan Enriquez

Managing Director, Excel Venture Management

Juan Enriquez a bestselling author of As the Future Catches You (an Amazon best book of year), The Untied States of America (Miami Herald’s book of the decade), Homo evolutis: a Tour of the Next Human Species (with Steve Gullans and TED). Rem Koolhaas chose his Map of Global Nucleotide Data Flow (done with West and Martinez) as an iconic example of 21st century design.
Fortune profiled him as “Mr. Gene.” Wired as “Darwin for the DNA Age.” He has helped found or guide over a dozen tech start ups including Synthetic Genomics, Zip Car, Xcellerex, Activate Networks. He sailed around the world with Dr. J. Craig Venter on a sampling expedition that increased the number of known genes by 10X. He negotiated a peace treaty with the Zapatista rebels in Mexico and was the Founding Director of the Harvard Life Sciences Project.

Eric Schadt

Director of the Icahn Institute for Genomics and Multiscale Biology

Dr. Schadt is also Chair of the Department of Genetics and Genomics Sciences, and the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at Mount Sinai. Dr. Schadt is an expert on the generation and integration of very large-scale sequence variation, molecular profiling and clinical data in disease populations for constructing molecular networks that define disease states and link molecular biology to physiology.
He has published more than 200 peer-reviewed papers in leading scientific journals, and contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes, obesity, and Alzheimer’s disease.
Prior to joining Mount Sinai in 2011, he was Chief Scientific Officer at Pacific Biosciences, the next-generation sequencing technology provider. He received his B.A. in applied mathematics and computer science from California Polytechnic State University, his M.A. in pure mathematics from University of California, Davis, and his PhD. in bio-mathematics from University of California, Los Angeles.
Eric Schadt